| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 521.74 | 505.62 | 385.84 | 318.18 |
| Receivables | 228.41 | 225.84 | 218.16 | 315.94 |
| Inventory | 343.64 | 355.91 | 326.00 | 375.26 |
| Other | 26.61 | 46.62 | 54.47 | 52.03 |
| 1,120.40 | 1,133.99 | 984.47 | 1,061.40 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 157.93 | 170.20 | 136.39 | 188.19 |
| ST’ Debt | — | — | — | — |
| Other | 24.96 | 21.86 | 22.17 | 22.89 |
| 218.56 | 233.72 | 211.28 | 264.88 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 731.15 | 814.08 | — | — |
—
|
| ’25 | 709.23 | 780.11 | 748.87 | 715.80 |
2,954.01
|
| ’24 | 726.24 | 768.36 | 747.29 | 710.64 |
2,952.53
|
| ’23 | 797.90 | 815.97 | 809.98 | 712.53 |
3,136.38
|
| ’22 | 1,302.31 | 1,239.38 | 1,060.76 | 847.77 |
4,450.21
|
| ’21 | 1,025.47 | 1,307.91 | 970.84 | 972.95 |
4,277.18
|
| ’20 | 662.07 | 698.78 | 871.06 | 865.42 |
3,097.33
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (57.23) | 11.18 | — | — |
—
|
| ’25 | (33.91) | (26.76) | 58.62 | 61.83 |
59.78
|
| ’24 | (31.13) | 35.80 | 61.77 | 18.74 |
85.18
|
| ’23 | 88.97 | 64.15 | 77.61 | 75.56 |
306.29
|
| ’22 | 2.24 | 101.19 | 142.61 | 154.26 |
400.30
|
| ’21 | (24.61) | 47.21 | 104.26 | 18.16 |
145.02
|
| ’20 | (59.19) | 72.09 | 61.50 | (19.38) |
55.02
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (59.80) | 8.86 | — | — |
—
|
| ’25 | (37.30) | (36.30) | 52.69 | 56.42 |
35.51
|
| ’24 | (36.45) | 29.50 | 54.40 | (1.47) |
45.97
|
| ’23 | 79.99 | 59.21 | 72.77 | 67.15 |
279.12
|
| ’22 | (0.22) | 97.30 | 130.53 | 137.77 |
365.38
|
| ’21 | (23.92) | 45.72 | 99.63 | 19.50 |
140.94
|
| ’20 | (60.39) | 71.64 | 71.94 | (19.02) |
64.18
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.18) | 0.81 | — | — |
—
|
| ’25 | 0.34 | 0.54 | 0.20 | (1.08) |
0.02
|
| ’24 | 2.00 | 1.65 | 1.87 | 0.62 |
6.19
|
| ’23 | 1.94 | 2.70 | 2.71 | (2.08) |
5.39
|
| ’22 | 13.19 | 7.48 | 6.38 | 3.50 |
31.51
|
| ’21 | 6.28 | 11.61 | 4.74 | 7.30 |
29.99
|
| ’20 | (0.08) | 0.71 | 5.72 | 2.04 |
8.55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 57.50 | 61.80 | 87.67 | 52.71 | — | — | — |
Low Price
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 100.01 | 117.09 | 134.79 | 114.19 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,100 | 2,000 | 2,000 | 2,160 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.12 | 1.57 | 1.48 | 1.37 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,450.21 | 3,136.38 | 2,952.53 | 2,954.01 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.72% | 16.80% | 16.57% | 15.29% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 394.76 | 81.89 | 70.69 | 0.13 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.87% | 2.61% | 2.39% | 0.00% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 296.18 | 48.54 | 53.12 | 0.22 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.83 | 33.36 | 39.81 | 41.42 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 477.08 | 348.99 | 346.09 | 369.99 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 31.75 | 5.40 | 6.22 | 0.02 | ‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.91 | 34.08 | 9.98 | 7.49 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.74) | (3.02) | (4.60) | (3.04) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.17 | 31.06 | 5.39 | 4.45 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 63.25 | 70.58 | 75.78 | 77.32 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.33 | 8.99 | 8.53 | 7.98 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.35 | 20.89 | 16.53 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.15 | 0.32 | 0.30 | 0.17 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.16 | 1.57 | 1.35 | 0.79 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.22 | 0.34 | 0.32 | 0.24 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.63 | 3.79 | 20.84 | 20.20 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 400.30 | 306.29 | 85.18 | 59.78 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (34.92) | (27.16) | (39.21) | (24.28) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 365.38 | 279.12 | 45.97 | 35.51 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 866.26 | 901.84 | 900.26 | 773.19 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 573.41 | 567.99 | 575.06 | 595.59 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 274.47 | 46.25 | 69.44 | 209.75 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 590.03 | 634.29 | 646.44 | 617.32 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.10% | 3.21% | 3.41% | 0.01% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.74% | 12.72% | 7.65% | 2.45% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 62.14% | 7.93% | 8.29% | 0.03% | — | — | — |
ROE
|
BlueLinx Holdings (BXC), a major distributor of building products tied to the ups and downs of housing and construction, rode a wild pandemic boom to record revenues of $4.45 billion in 2022, with fat gross margins hitting 18.7% and EPS exploding to $31.75. But the Fed’s rate hikes slammed the brakes—revenues tumbled 30%+ since then to $2.95 billion in 2024, earnings cratered 84% in 2023, and analysts now forecast a brutal 95% EPS drop to just $0.33 in 2025 before a shaky rebound.
Bright spots include a beefed-up balance sheet with net debt slashed 85% to $69 million, rising shareholder equity, and insider buying like the CFO’s recent $499K purchase signaling confidence. Cash flows, while down sharply from 2022 gushers, still support deleveraging, and valuations look reasonable at 0.3x sales—not screaming cheap, but not overpriced for a cyclical play.
The road ahead hinges on housing stabilization amid sticky rates and recession risks, with competition and debt adding caution. For patient investors bottom-fishing the cycle, BXC offers tactical upside if cash flows hold steady—but size positions small and watch for FCF slips in upcoming earnings. Dive into the full analysis for the numbers that matter.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.